Cargando…
Arterial stiffness in patients with type 1 diabetes and its comparison to cardiovascular risk evaluation tools
BACKGROUND: Arterial stiffness is a potential biomarker for cardiovascular disease (CVD) risk in patients with type 1 diabetes (T1D). However, its relation with other CV risk evaluation tools in T1D has not been elucidated yet. This study aimed to evaluate arterial stiffness in T1D patients free fro...
Autores principales: | Helleputte, Simon, Van Bortel, Luc, Verbeke, Francis, Op ‘t Roodt, Jos, Calders, Patrick, Lapauw, Bruno, De Backer, Tine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185867/ https://www.ncbi.nlm.nih.gov/pubmed/35681143 http://dx.doi.org/10.1186/s12933-022-01537-1 |
Ejemplares similares
-
Time-varying parameters of glycemic control and glycation in relation to arterial stiffness in patients with type 1 diabetes
por: Helleputte, Simon, et al.
Publicado: (2022) -
The impact of diabetic neuropathy on the distal versus proximal comparison of weakness in lower and upper limb muscles of patients with type 2 diabetes mellitus: a cross-sectional study
por: Eetvelde, Birgit L.M. Van, et al.
Publicado: (2021) -
Arterial stiffness, central hemodynamics, and cardiovascular risk in hypertension
por: Palatini, Paolo, et al.
Publicado: (2011) -
Body composition is a strong predictor of local carotid stiffness in Swedish, young adults – the cross sectional Lifestyle, biomarkers, and atherosclerosis study
por: Fernberg, Ulrika, et al.
Publicado: (2019) -
Acute Effects of Cocoa Flavanols on Blood Pressure and Peripheral Vascular Reactivity in Type 2 Diabetes Mellitus and Essential Hypertension: A Protocol for an Acute, Randomized, Double-Blinded, Placebo-Controlled Cross-Over Trial
por: Tanghe, Anouk, et al.
Publicado: (2021)